Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published March 2012 | Published
Journal Article Open

Phospholipase C-ζ-induced Ca^(2+) oscillations cause coincident cytoplasmic movements in human oocytes that failed to fertilize after intracytoplasmic sperm injection

Abstract

OBJECTIVE: To evaluate the imaging of cytoplasmic movements in human oocytes as a potential method to monitor the pattern of Ca^(2+) oscillations during activation. DESIGN: Test of a laboratory technique. SETTING: University medical school research laboratory. PATIENT(S): Donated unfertilized human oocytes from intracytoplasmic sperm injection (ICSI) cycles. INTERVENTION(S): Microinjection of oocytes with phospholipase C (PLC) zeta (ζ) cRNA and a Ca^(2+)-sensitive fluorescent dye. MAIN OUTCOME MEASURE(S): Simultaneous detection of oocyte cytoplasmic movements using particle image velocimetry (PIV) and of Ca^(2+) oscillations using a Ca^(2+)-sensitive fluorescent dye. RESULT(S): Microinjection of PLCζ cRNA into human oocytes that had failed to fertilize after ICSI resulted in the appearance of prolonged Ca^(2+) oscillations. Each transient Ca^(2+) concentration change was accompanied by a small coordinated movement of the cytoplasm that could be detected using PIV analysis. CONCLUSION(S): The occurrence and frequency of cytoplasmic Ca^(2+) oscillations, a critical parameter in activating human zygotes, can be monitored by PIV analysis of cytoplasmic movements. This simple method provides a novel, noninvasive approach to determine in real time the occurrence and frequency of Ca^(2+) oscillations in human zygotes.

Additional Information

© 2012 American Society for Reproductive Medicine. Published by Elsevier Under a Creative Commons license (Attribution 3.0 Unported (CC BY 3.0)) Received 18 October 2011, Revised 6 December 2011, Accepted 9 December 2011, Available online 2 January 2012. K.S. has nothing to disclose. S.W. has nothing to disclose. K.C. has nothing to disclose. K.E. has nothing to disclose. M.N. has nothing to disclose. M.Z.-G. has nothing to disclose. N.A. has nothing to disclose. F.A.L. has nothing to disclose. A.T. has nothing to disclose. C.G. has nothing to disclose. This work was supported by Wellcome Trust grants awarded to A.T., M.Z.-G., and K.S. (085107/Z/08/Z) and to K.S. and F.A.L. (080701/Z/06/Z). K.E. is supported by a Scholarship from the Libyan Government.

Attached Files

Published - 1-s2.0-S0015028211028652-main.pdf

Files

1-s2.0-S0015028211028652-main.pdf
Files (383.5 kB)
Name Size Download all
md5:c7048cd7c7a5508a051c08c38b5dfbd3
383.5 kB Preview Download

Additional details

Created:
August 22, 2023
Modified:
October 20, 2023